eli lilly & co
(LLY:New York Consolidated)

Executive Profile*

Background*

Dr. Franklyn G. Prendergast, M.D., Ph.D. serves as a Member of Management Board/Member of Board of Managers at IllinoisVENTURES, LLC. Dr. Prendergast serves as a Member of Life Sciences Advisory Board of Safeguard Scientifics, Inc. Dr. Prendergast is a Member of several national boards. He has been Director of Cancer Genetics, Inc since 2012. Dr. Prendergast also serves on the Scientific Advisory Boards of several prominent academic institutions and of several biotechnology ... firms. He serves on the board of directors for DemeRx, Inc., and Ativa Medical Corporation. He has been a Director of Eli Lilly & Co. since April 1995. He has been a Member of Medical Advisory Board at DiaTech Oncology Corp., since September 2012. He serves as the Director of Mayo Clinic Center for Individualized Medicine, LifeSync Holdings, Inc., St. Mary's and Methodist Hospitals in Rochester, The Translational Genomics Research Institute, GMP Companies Inc., Cellumen Inc., The Hamm Clinic, the Infectious Diseases Research Institute and Radiation Effects Research, National Academy of Sciences. He has served as a charter member of the Board of Advisors for the Division of Research Grants, (the Center for Scientific Review); the National Advisory General Medical Sciences Council. Dr. Prendergast is a Trustee at Mayo Foundation For Medical Education And Research. He has been a Member of Scientific Advisory Board of Cepheid since September 12, 2007 and also serves on the Board of Scientific Advisors for the National Cancer Institute, Cellomics and serves as a Member of the American Chemical Society Committee on Chemistry and Public Affairs. Dr. Prendergast is a Member of the American Chemical Society, American Society for Photobiology, American Association for the Advancement of Science, Biophysical Society, Sigma Xi, and the American Society for Biochemistry and Molecular Biology. He has served the National Institutes of Health extensively over the last 20 years with roles on numerous advisory groups and boards. He served as Director of Mayo Clinic Cancer Center from 1994 to 2006. He held a Presidential Commission for service on the National Cancer Advisory Board. Dr. Prendergast also has served in numerous other advisory roles for the National Institute of Health and the National Research Council of the National Academy of Sciences. He served as Director of Research of Mayo Rochester since 1992. Dr. Prendergast also served as an Internal Trustee of Mayo Clinic Rochester and on numerous National Institutes of Health Advisory Boards. He is a Professor of Pharmacology and Biochemistry/Molecular Biology at the College of Medicine at Mayo Clinic, and Director, Mayo Clinic Center for Individualized Medicine. Dr. Prendergast has been a Professor of Molecular Pharmacology and Experimental Therapeutics of Mayo Medical School since 1986. Since 1977, he served as an Assistant Professor in Pharmacology of the Mayo Medical School. He held several other teaching positions including Instructor of Physiology at the Mayo Medical School since 1975. Dr. Prendergast has authored more than 300 published abstracts and full papers. He has received numerous national awards, fellowships and honors including E.E. Just Awardee of the American Society of Cell Biology and the Musgrave Gold Medal of the Institute of Jamaica. In addition, he was awarded the Distinguished Lecturer in Medical Sciences awards, and recognized as an Established Investigator from the American Heart Association. Dr. Prendergast has been the recipient of Edmond and Marion Guggenheim Professor of Biochemistry and Molecular Biology in 1987 and Mayo Distinguished Investigator in 1988. His research focus is on structural protein biology and bio imaging. Dr. Prendergast received an Honorary Doctorate from Purdue University. He completed his PhD in Biochemistry from the University of Minnesota, in 1977; M.A. in Physiology from Oxford University in 1979; Bachelor of Arts Degree in Physiology from Oxford University in 1971; and studied degree in Medicine at the University of the West Indies in 1968.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
LLY:US	$55.14 USD	+0.12

COMPETITOR COMPENSATION